CINV — Crucial Innovations Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Crucial Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.031 | -0.023 | -0.044 | -0.04 | -91.1 |
| Depreciation | |||||
| Non-Cash Items | 0.012 | — | 0.001 | 0.002 | 90.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.013 | -0.001 | 0.008 | 0.007 | -0.277 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.006 | -0.024 | -0.035 | -0.031 | -1.19 |
| Capital Expenditures | — | — | — | — | -0.019 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.006 |
| Sale of Business | |||||
| Cash from Investing Activities | — | — | — | — | -0.013 |
| Financing Cash Flow Items | — | — | 0.035 | 0.031 | 1.23 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.006 | 0.024 | 0.035 | 0.031 | 1.22 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0 | 0 | 0.053 |